The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors and investigators in the Prostate Testing for Cancer and Treatment (ProtecT) trial, which randomized care for 2,664 men. Findings from the trial were published in the New England Journal of Medicine.
Hitachi Aloka Medical America recently announced the support of its Arietta 70 and Arietta 60 ultrasound systems with iVu Imaging Corp.’s Sofia 3-D whole-breast imaging system. The Hitachi Arietta platform and its long linear transducer enable the Sofia system to automate the 3-D radial acquisition of an entire breast in nearly half the time of previous-generation ultrasound systems.
Agfa HealthCare has expanded its DX-D Retrofit line with the DX-D 60. This versatile, vendor-neutral direct radiography (DR) detector easily fits into existing radiography rooms and provides DR workflow without the higher cost of room replacement. In addition to virtually instant image access, technologists do not have to rotate the 17x17 inch DX-D 60 for radiology exams that would otherwise require portrait and landscape detector rotations, thus greatly improving image acquisition speed and workflow.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
New research suggests enhanced, culturally-competent communication with early-stage lung cancer patients can narrow racial gaps in curative treatment completion and increase treatment rates for all races. The study, part of a project supported by the National Cancer Institute, found that multiple, coordinated modalities of patient support essentially eliminated the inequity in curative treatment and improved completion of care for all patients.
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to new research. Women receiving IMRT reported significantly fewer bowel and bladder problems than those receiving conventional radiation treatment.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The Medicare Shared Savings Program (MSSP) has produced small but significant improvements in mammography utilization in its first three years, according to a new study published online in the journal Radiology.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Although approximately 50 percent of cancer patients in developing countries need radiation therapy (RT), up to half of these patients do not have access to it, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. The findings were presented at the American Society for Radiation Oncology (ASTRO) meeting, Sept. 25-28 in Boston.
If we are to look forward to the development of smartphone technology for radiology applications, we might do well to look at virtual and augmented realities. For decades, radiology has fiddled with these.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Samsung announced recently that The University of Texas MD Anderson Cancer Center in Houston added BodyTom CT, the world’s first portable, full-body, 32-slice computed tomography (CT) scanner to its Proton Therapy Center. The center is now treating patients using images from the scanner as part of the process.
September 28, 2016 – Addressing the educational needs of an underserved and growing population, DenseBreast-info.org now ...
Survival rates for elderly patients receiving stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
September 27, 2016 — For men with early stage, low-risk prostate cancer, hypofractionated radiation therapy (RT) offers ...
September 27, 2016 — Carestream Health announced that it will be displaying a wide range of products at the 2016 Annual ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT). These findings were drawn from research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
Elekta announced that it has expanded its partnership with Radiating Hope, a volunteer organization that provides radiation equipment to resource-constrained countries. The organization also educates medical physics and radiation oncology personnel in those countries to help better serve their patient populations.
In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival. Identifying these subtypes can assist in future research to determine how patients will respond to treatment, according to research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO). Findings represent a step toward the implementation of personalized medicine in prostate cancer care.
RaySearch and Mevion Medical Systems are extending their collaboration agreement to support the RayCare oncology information system (OIS), currently in development at RaySearch, and to take full advantage of the advanced treatment capabilities of the Mevion S250i with Hyperscan and Adaptive Aperture. The agreement was announced at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.
September 26, 2016 — A new analysis of Veteran’s Affairs Central Cancer Registry records demonstrates a clear positive ...
September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined ...